← Open Payments lookup

THERESA HOWARD: Open Payments

NPI 1023615333 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$608 in 23 payments from 10 companies in 2025. Trend: 2023 $30 · 2024 $97 · 2025 $608

Food & beverage: $608
CompanyPaymentsAmount
United Therapeutics Corporation7$206
Bayer Healthcare Pharmaceuticals Inc.3$79
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Merck Sharp & Dohme LLC2$59
Takeda Pharmaceuticals U.S.A., Inc.2$57
ABBVIE INC.2$51
Actelion Pharmaceuticals US, Inc.1$31
Merit Medical Systems Inc1$22
Verona Pharma, Inc.1$21
Melinta Therapeutics, LLC1$19

Products named: Remodulin, Adempas, Orenitram, LIVTENCITY, JASCAYD, KEYTRUDA, UPTRAVI, EMBLAVEO.

Industry payments across DC — which companies pay providers there.